Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;99(6):1397-1406.
doi: 10.4269/ajtmh.18-0185.

Mycobacterium tuberculosis Drug Resistance and Transmission among Human Immunodeficiency Virus-Infected Patients in Ho Chi Minh City, Vietnam

Affiliations

Mycobacterium tuberculosis Drug Resistance and Transmission among Human Immunodeficiency Virus-Infected Patients in Ho Chi Minh City, Vietnam

Trinh Quynh Mai et al. Am J Trop Med Hyg. 2018 Dec.

Abstract

Vietnam has a high burden of tuberculosis (TB) and multidrug-resistant (MDR) TB, but drug resistance patterns and TB transmission dynamics among TB/human immunodeficiency virus (HIV) coinfected patients are not well described. We characterized 200 Mycobacterium tuberculosis isolates from TB/HIV coinfected patients diagnosed at the main TB referral hospital in Ho Chi Minh City, Vietnam. Phenotypic drug susceptibility testing (DST) for first-line drugs, spoligotyping, and 24-locus mycobacterial interspersed repetitive unit (MIRU-24) analysis was performed on all isolates. The 24-locus mycobacterial interspersed repetitive unit clusters and MDR isolates were subjected to whole genome sequencing (WGS). Most of the TB/HIV coinfected patients were young (162/174; 93.1% aged < 45 years) males (173; 86.5% male). Beijing (98; 49.0%) and Indo-Oceanic (70; 35.0%) lineage strains were most common. Phenotypic drug resistance was detected in 84 (42.0%) isolates, of which 17 (8.5%) were MDR; three additional MDR strains were identified on WGS. Strain clustering was reduced from 84.0% with spoligotyping to 20.0% with MIRU-24 typing and to 13.5% with WGS. Whole genome sequencing identified five additional clusters, or members of clusters, not recognized by MIRU-24. In total, 13 small (two to three member) WGS clusters were identified, with less clustering among drug susceptible (2/27; 7.4%) than among drug-resistant strains (25/27; 92.6%). On phylogenetic analysis, strains from TB/HIV coinfected patients were interspersed among strains from the general community; no major clusters indicating transmission among people living with HIV were detected. Tuberculosis/HIV coinfection in Vietnam was associated with high rates of drug resistance and limited genomic evidence of ongoing M. tuberculosis transmission among HIV-infected patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Drug resistance mutations identified in different Mycobacterium tuberculosis strain lineages.
Figure 2.
Figure 2.
Phylogenetic tree of sequenced* Mycobacterium tuberculosis strains from patients with tuberculosis/human immunodeficiency virus coinfection in Ho Chi Minh City, Vietnam. Multidrug resistant (MDR): resistant to at least isoniazid and rifampicin; *All strains that were drug resistant (84) or clustered by 24-locus mycobacterial interspersed repetitive unit (40) were sequenced; Red circles indicate identified clusters; Black circles indicate possible cluster.
Figure 3.
Figure 3.
Mycobacterium tuberculosis strains identified in tuberculosis/HIV coinfected patients in Ho Chi Minh City, Vietnam, compared with community strains identified among non-HIV–infected patients.* DR = drug resistant; DS = drug susceptible; HIV = human immunodeficiency virus; MDR = multidrug resistant. *Sequence data for community M. tuberculosis strains were derived from Holt et al.
Figure 4.
Figure 4.
Comparison of branch length by Mycobacterium tuberculosis strain lineage in HIV-infected and uninfected patients. HIV = human immunodeficiency virus. This figure appears in color at www.ajtmh.org.

Similar articles

Cited by

References

    1. World Health Organization , 2017. Global Tuberculosis Report, 2017. Geneva, Switzerland: WHO.
    1. Abubakar I, et al. 2013. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 13: 529–539. - PubMed
    1. McBryde ES, Meehan MT, Doan TN, Ragonnet R, Marais BJ, Guernier V, Trauer JM, 2017. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. Int J Infect Dis 56: 14–20. - PubMed
    1. Zhang Y, Yew W, 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13: 1320–1330. - PubMed
    1. Zhao Y, et al. 2012. National survey of drug-resistant tuberculosis in China. N Engl J Med 366: 2161–2170. - PubMed

Publication types

MeSH terms

Substances